Understanding CAR T-Cell Therapy: Guidance for Current Clinic and Future Directions

Download All
In this comprehensive program, gain expert perspectives on how managed care and specialty pharmacy professionals can integrate CAR T-cell therapy into the care of patients with hematologic malignancies. Download the slideset and watch the on-demand webcast capturing a live CCO webinar, then read an FAQ featuring expert answers to healthcare professionals’ questions on CAR T-cell therapy.
Zahra Mahmoudjafari, PharmD, BCOP, DPLA


As more patients are treated with CAR T-cell therapies, pharmacists in both community and academic practices are becoming essential to patient care. In this commentary, I review key topics in CAR T-cell therapy that pharmacists should know and provide recommendations for those practicing in the community and in centers authorized to administer CAR T-cell therapy.

Zahra Mahmoudjafari, PharmD, BCOP, DPLA Released: October 11, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Bristol-Myers Squibb

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings